Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.
Related Posts
McDonald’s to invest more than $100 million to speed up recovery after E. coli outbreak
This week, the company completed the return of Quarter Pounder burgers, with slivered onions, to all restaurant menus nationwide.
These airlines were the most on-time in 2024
Supply chain issues and strong travel demand continued in 2024.
Alibaba’s Tsai discusses AI’s potential: ‘Research analysts can be completely replaced’
“Mundane research” can be done by machines, but human beings will still play a role, Alibaba’s Chairman Joe Tsai said Wednesday at CNBC’s CONVERGE LIVE.